Tsuchida M, Takai K, Jojima K, Naito K, Fujikura Y, Fukumoto T
Department of Urology, Yamaguchi University School of Medicine, Japan.
Ther Immunol. 1994 Jun;1(3):135-41.
We investigated the effects of FK506 and glucocorticoids (GC) on rat thymocytes using flow cytofluorometry. Rats were treated with GC (0.1 mg/body, by single injection), with FK506 (1 mg/kg/day, for 7 days), or with FK506 and GC. GC alone significantly decreased the percentage of CD4+8+ thymocytes and increased the percentages of CD4-8-, CD4+8- and CD4-8+ thymocytes on day 7. FK decreased the percentage of CD4+8- and CD4-8+ thymocytes and increased the percentage of CD4+8+ thymocytes on days 5 to 14. FK and GC induced a significant decrease in the number of CD4+8+ thymocytes greater than that seen with GC alone on day 7. The absolute number of TCR alpha beta high MHC class Ihigh thymocytes after FK and GC was significantly lower than that of the control group, and was slightly lower than that after FK alone on day 14. These results suggest that combined treatment with FK506 and GC acts complexly to decrease rat CD4+8+ thymocytes and prevents thymocyte differentiation and maturation.
我们使用流式细胞荧光术研究了FK506和糖皮质激素(GC)对大鼠胸腺细胞的影响。大鼠分别接受GC(0.1mg/只,单次注射)、FK506(1mg/kg/天,持续7天)或FK506与GC联合处理。单独使用GC在第7天时显著降低了CD4+8+胸腺细胞的百分比,并增加了CD4-8-、CD4+8-和CD4-8+胸腺细胞的百分比。FK在第5至14天时降低了CD4+8-和CD4-8+胸腺细胞的百分比,并增加了CD4+8+胸腺细胞的百分比。在第7天时,FK和GC联合处理诱导的CD4+8+胸腺细胞数量的减少比单独使用GC时更为显著。在第14天时,FK和GC联合处理后TCRαβ高MHC I类高胸腺细胞的绝对数量显著低于对照组,且略低于单独使用FK后的数量。这些结果表明,FK506和GC联合处理以复杂的方式作用于减少大鼠CD4+8+胸腺细胞,并阻止胸腺细胞的分化和成熟。